Cervical Dystonia and Chronic Migraine Comorbidity: Background, Diagnosis, and Treatment
OnabotulinumtoxinA in Cervical Dystonia
Botulinum Toxins: Dosing and Duration of Treatment
OnabotulinumtoxinA: Manufacturing, Non-interchangeability, and Non-Medical Switching
Please see Important Safety Information within the video.
Please see full Prescribing Information including Boxed Warning and Medication Guide here.
Mitchell Brin, MD, FAAN, FANA, FAHS
Senior Vice President, R&D
Chief Scientific Officer, Neurotoxins
Clinical Professor of Neurology,
University of California, Irvine
Jack W. Tsao, MD, DPhil
Edwin H. Kolodny, MD Professor of Neurology
Department of Neurology
NYU Grossman School of Medicine
New York, NY
Learn how onabotulinumtoxinA is made, why botulinum toxins are non-interchangeable and why it matters.
This site is intended for U.S. Healthcare Professionals only. Use of and access to this site are subject to the Terms of Use and Privacy Policy.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.
Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A. BONT-US-00017-MC. V2, May 2024.